InnoPharmax Inc. (4172)
Market Closed
12 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
11. 25
-0.05
-0.4425%
NT$
- Market Cap
- P/E Ratio
88% Div Yield
196,465 Volume
- Eps
NT$ 11.3
Previous Close Want to track 4172 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoPharmax Inc. (4172) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.23B
Trailing P/E (ttm) -6.56
Forward P/E -
PEG ratio 0.1
Price/Sales (ttm) 19.04
Price/Book (mrq) 2.88
Enterprise Value/Revenue 17.79
Enterprise Value/EBITDA -7.32
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 342.85K
Average volume (90 days) 353.55K
Price summary
52-Week low 10.1
52-Week high 23.75
Beta -
50-Day moving average 11.49
200-Day moving average 13.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 507:500
Last split Date 7 Apr 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.67%
Operating margin -2.49%
Operational effectiveness
Return on assets -0.39%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.43
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 3.52%
Book value per share (mrq) 3.87
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
